Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two …
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
 Apyx Medical (APYX) Q2 2026 Earnings Call Transcript AYON adoption accelerated 22% as surgeons target GLP-1 weight-loss patients. | ||
 Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring Apyx Medical (NASDAQ:APYX) is positioning its Renuvion technology and newly launched AYON Body Contouring System to address growing demand for surgical aesthetic procedures, a trend CEO Charlie Goodwin said has been reshaped by the increasing use of GLP-1 weight-loss drugs. Speaking at the Canaccor | ||
Apyx Medical Corp (APYX) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on Power Lipo ... Company capitalizes on expanded FDA clearance and growing body contouring demand, reaffirming full-year guidance despite margin headwinds. | ||
 Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates Apyx (APYX) delivered earnings and revenue surprises of -16.67% and +10.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 Apyx Medical Q2 Earnings Call Highlights Apyx Medical (NASDAQ:APYX) reported second-quarter revenue growth of 22% as sales in its surgical aesthetics business increased, led by adoption of its AYON Body Contouring System, international generator sales and domestic demand for single-use handpieces. Total revenue for the quarter ended June | ||
IInsider Monkey | ||